NCT04532203

Clinical Trial for the Safety and Efficacy of CAR-T Cells Therapy for Patients With the Central Nervous System Involvement of Relapsed and/or Refractory B-cell Acute Lymphoblastic Leukemia or B-cell Non-Hodgkin's Lymphoma

Study Summary

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

Interested in this trial?

Submit an Inquiry

Interventions

CAR-T cellsDRUG
Each subject receive CAR T-cells by intravenous infusion
Ommaya ReservoirPROCEDURE
Surgical catheter placement into the fourth ventricle of the brain

Study Locations

FacilityCityStateCountry
The First Affiliated Hospital,College of Medicine, Zhejiang UniversityHangzhouZhejiangChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: May 29, 2026